Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2023.Mar.23

Update the related information regarding the leased office space in Taipei Bioinnovation Park

2023.Mar.13

Announcement of not Distributing Dividends in 2022

2023.Mar.13

The Company’s BOD resolved the plan to disperse shareholding of Obigen Pharma Inc.

2023.Mar.13

Announcement for the appointment of Corporate Governance Officer of the Company

2023.Mar.13

The Company’s BOD resolved the plan to disperse shareholding of AP Biosciences

2023.Mar.13

The Company's Board of Directors resolved to convene the 2023 Annual General Shareholders' Meeting

2023.Mar.13

Announcement of 2022 Consolidated Financial Statements were approved by the Board of Directors

2023.Mar.07

Announcement on behalf of AP Biosciences of not Distributing Dividends of 2022

2023.Mar.07

Announcement on behalf of AP Biosciences that the BOD resolved to convene the 2023 Annual General Shareholders' Meeting

2023.Feb.16

The first-in-class novel prodrug, OBI-3424, has been granted by TFDA to proceed to Phase II clinical trial

News

Latest News

Events

Latest events